NASDAQ:QNTM - Nasdaq - CA74764Y2050 - Common Stock - Currency: USD
QUANTUM BIOPHARMA LTD
NASDAQ:QNTM (2/4/2025, 5:33:59 PM)
After market: 6.38 -0.33 (-4.92%)6.71
+3.53 (+111.01%)
The current stock price of QNTM is 6.71 USD. In the past month the price increased by 67.33%.
Curious to know what's happening on the US markets one hour before the close of the markets on Tuesday? Join us as we explore the top gainers and losers in today's session.
Stay up-to-date with the latest market trends in the middle of the day on Tuesday. Explore the top gainers and losers during today's session in our detailed report.
Let's delve into the US markets on Tuesday and uncover the stocks that are experiencing notable gaps in today's session. Below, you'll find the gap up and gap down stocks.
The US market session of Tuesday has yet to be opened, let's have a look at the top gainers and losers in the pre-market session today.
Shares of Quantum BioPharma Ltd. (NASDAQ: QNTM) are soaring more than 70% on Tuesday after the company announced positive clinical trial results for its dietary supplement, unbuzzd, which accelerates the reduction of blood alcohol concentration.
Symbol | Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
LLY | ELI LILLY & CO | 81.23 | 784.20B | ||
JNJ | JOHNSON & JOHNSON | 15.36 | 369.55B | ||
NVO | NOVO-NORDISK A/S-SPONS ADR | 28.2 | 366.85B | ||
MRK | MERCK & CO. INC. | 15.25 | 229.54B | ||
AZN | ASTRAZENECA PLC-SPONS ADR | 18.1 | 213.85B | ||
NVS | NOVARTIS AG-SPONSORED ADR | 13.32 | 210.86B | ||
PFE | PFIZER INC | 10.03 | 146.61B | ||
SNY | SANOFI-ADR | 14.82 | 134.13B | ||
BMY | BRISTOL-MYERS SQUIBB CO | 50.53 | 119.91B | ||
ZTS | ZOETIS INC | 29.9 | 77.71B | ||
GSK | GSK PLC-SPON ADR | 8.46 | 71.08B | ||
TAK | TAKEDA PHARMACEUTIC-SP ADR | 22.2 | 42.23B |
Quantum BioPharma Ltd is a CA-based company operating in Pharmaceuticals industry. The company is headquartered in Toronto, Ontario. The company went IPO on 2018-05-29. Quantum BioPharma Ltd. is a Canada-based biopharmaceutical company. The firm is engaged in building a portfolio of assets and biotech solutions for the treatment of challenging neurodegenerative and metabolic disorders and alcohol misuse disorders with drug candidates in different stages of development. Through its wholly owned subsidiary, Lucid Psycheceuticals Inc. (Lucid), it is focused on the research and development of its lead compound, Lucid-MS, which is a patented new chemical entity to prevent and reverse myelin degradation, the underlying mechanism of multiple sclerosis. Its unbuzzd beverage is a proprietary formulation of vitamins and minerals to help with liver and brain function for the purposes of relieving the effects of alcohol consumption and restoring a normal lifestyle. The company maintains a portfolio of strategic investments through its wholly owned subsidiary, FSD Strategic Investments Inc., which represents loans secured by residential or commercial property.
QUANTUM BIOPHARMA LTD
First Canadian Place, 100 King Street West, Suite 4000
TORONTO ONTARIO CA
Employees: 10
Company Website: https://www.fsdpharma.com/
Investor Relations: http://www.fsdpharma.com/investors
Phone: 14168548884
The current stock price of QNTM is 6.71 USD.
The exchange symbol of QUANTUM BIOPHARMA LTD is QNTM and it is listed on the Nasdaq exchange.
QNTM stock is listed on the Nasdaq exchange.
Always make your own analysis. On these pages you can find a full technical and fundamental analysis report for QNTM, which may be a starting point for your analysis. You can also find the financials, news, analyst ratings and estimates here, which can be used to increase your understanding of QNTM.
QNTM does not pay a dividend.
The outstanding short interest for QNTM is 2.46% of its float.
ChartMill assigns a technical rating of 4 / 10 to QNTM.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | N/A | ||
ROA | N/A | ||
ROE | N/A | ||
Debt/Equity | N/A |
ChartMill assigns a Buy % Consensus number of 83% to QNTM. The Buy consensus is the average rating of analysts ratings from 7 analysts.